Interleukin-1α alters megakaryocyte maturation, promotes emperipolesis, and induces a distinct proteomic profile

Robert Kolman1, Hannah Voß2, Ivana Bertović1

  • 1Laboratory for Hematopoiesis, Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia.

Abstract

Insights

Interleukin-1α (IL-1α) promotes megakaryocyte (MK) maturation and platelet production, influencing emperipolesis and immune cell interactions. This cytokine shapes an immune-driven proteomic phenotype in MKs during in vitro development.

Area of Science:

  • Hematology and Immunology
  • Cell Biology
  • Cytokine Signaling

Background:

  • Megakaryocytes (MKs) are precursors to platelets, crucial for hemostasis.
  • Interleukin-1α (IL-1α) is a proinflammatory cytokine involved in emergency thrombopoiesis.
  • The specific effects of IL-1α on MK maturation in vitro remain largely uncharacterized.

Purpose of the Study:

  • To investigate the phenotypical and molecular changes in MKs during IL-1α-induced maturation.
  • To compare IL-1α-driven maturation with standard thrombopoietin (TPO) treatment.
  • To elucidate the role of IL-1α in platelet biogenesis and immune cell interactions during MK development.

Main Methods:

  • Murine bone marrow cells were cultured in vitro with IL-1α and/or TPO.
  • MK maturation was analyzed at days 3 and 5, assessing morphology, ploidy, and platelet release.
  • Proteome analysis was performed on MKs to identify molecular changes.

Main Results:

  • IL-1α increased the number and size of MKs, enhanced ploidy, and boosted platelet-like particle release.
  • A significant increase in emperipolesis (neutrophils within MK cytoplasm) was observed, dependent on IL-1α.
  • Proteome analysis revealed elevated neutrophil-related, antimicrobial, and inflammation-related proteins in IL-1α-treated MKs.

Conclusions:

  • IL-1α modulates MK maturation, impacting platelet production and promoting emperipolesis.
  • IL-1α induces a distinct immune-driven proteomic phenotype in developing MKs.
  • These findings highlight a novel role for IL-1α in regulating MKs and their interaction with the immune system.